Summer Student Research Day returns to the RI-MUHC
A diverse group of young research trainees present their summer projects
Parasitic worms reprogram intestinal stem cells to evade the immune system
A new collaboration between immunoparasitologists and stem cell biologists at the RI-MUHC describes...
RI-MUHC cancer genetics expert honoured by UBC
Dr. William Foulkes receives the 2022 Dr. Chew Wei Memorial Prize in Cancer Research
RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer
A fatty acid metabolism enzyme drives prostate cancer aggressiveness...
RI-MUHC trainee awarded 2022 Vanier Canada Graduate Scholarship
Joan Miguel Romero is investigating T cell−inflammation in pancreatic cancer
RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
Immunotherapy showing significant advancements in lung cancer treatment
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
Where immune cells are located is critical for cancer immune therapy, a new study shows
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...
RI-MUHC team receives Discovery of the Year Award from Québec Science magazine
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...